DK143714B - METHOD FOR HYDROLYSE OF LACTOSE UNDER GLUCOSE AND GALACTOSE CREATION - Google Patents
METHOD FOR HYDROLYSE OF LACTOSE UNDER GLUCOSE AND GALACTOSE CREATION Download PDFInfo
- Publication number
- DK143714B DK143714B DK545175A DK545175A DK143714B DK 143714 B DK143714 B DK 143714B DK 545175 A DK545175 A DK 545175A DK 545175 A DK545175 A DK 545175A DK 143714 B DK143714 B DK 143714B
- Authority
- DK
- Denmark
- Prior art keywords
- lactose
- lactase
- growth
- galactose
- hydrolysis
- Prior art date
Links
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 title description 23
- 239000008101 lactose Substances 0.000 title description 23
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title description 10
- 239000008103 glucose Substances 0.000 title description 9
- 238000000034 method Methods 0.000 title description 8
- 229930182830 galactose Natural products 0.000 title description 5
- 108010005774 beta-Galactosidase Proteins 0.000 description 28
- 102100026189 Beta-galactosidase Human genes 0.000 description 26
- 108010059881 Lactase Proteins 0.000 description 26
- 229940116108 lactase Drugs 0.000 description 26
- 230000007062 hydrolysis Effects 0.000 description 14
- 238000006460 hydrolysis reaction Methods 0.000 description 14
- 235000013336 milk Nutrition 0.000 description 11
- 239000008267 milk Substances 0.000 description 11
- 210000004080 milk Anatomy 0.000 description 11
- 229920001817 Agar Polymers 0.000 description 10
- 239000008272 agar Substances 0.000 description 10
- 108090000790 Enzymes Proteins 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 229940088598 enzyme Drugs 0.000 description 7
- 241000193749 Bacillus coagulans Species 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 235000015097 nutrients Nutrition 0.000 description 6
- 229940054340 bacillus coagulans Drugs 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- KUWPCJHYPSUOFW-SCWFEDMQSA-N (2r,3r,4s,5r)-2-(hydroxymethyl)-6-(2-nitrophenoxy)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)OC1OC1=CC=CC=C1[N+]([O-])=O KUWPCJHYPSUOFW-SCWFEDMQSA-N 0.000 description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 239000005862 Whey Substances 0.000 description 3
- 102000007544 Whey Proteins Human genes 0.000 description 3
- 108010046377 Whey Proteins Proteins 0.000 description 3
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 206010023648 Lactase deficiency Diseases 0.000 description 2
- 201000010538 Lactose Intolerance Diseases 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000187432 Streptomyces coelicolor Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 102000005936 beta-Galactosidase Human genes 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 150000002823 nitrates Chemical class 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 241000194107 Bacillus megaterium Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 102100035882 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 238000009651 Voges-Proskauer test Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000005189 flocculation Methods 0.000 description 1
- 230000016615 flocculation Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000006916 nutrient agar Substances 0.000 description 1
- 238000009928 pasteurization Methods 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 108010009004 proteose-peptone Proteins 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C21/00—Whey; Whey preparations
- A23C21/02—Whey; Whey preparations containing, or treated with, microorganisms or enzymes
- A23C21/023—Lactose hydrolysing enzymes, e.g. lactase, B-galactosidase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2468—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on beta-galactose-glycoside bonds, e.g. carrageenases (3.2.1.83; 3.2.1.157); beta-agarase (3.2.1.81)
- C12N9/2471—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
- C12N9/86—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in cyclic amides, e.g. penicillinase (3.5.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01023—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
- C12Y305/02—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in cyclic amides (3.5.2)
- C12Y305/02006—Beta-lactamase (3.5.2.6)
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Description
09) DANMARK (^|)09) DENMARK (^ |)
|p (12) FREMUEGGELSESSKRIFT (ni 143714B| p (12) PREFACE SCRIPTURE (ni 143714B
DIREKTORATET FOR PATENT- OG VAREMÆRKEVÆSENETDIRECTORATE OF THE PATENT AND TRADEMARKET SYSTEM
(21) Ansøgning nr. 5^51/75 (51) lnt.CI.3 C 12 P 19/14 (22) Indleveringsdag 3· dec. 1975 (24) Løbedag 5· dec. 1975 (41) Aim. tilgængelig 5· jun. 1976 (44) Fremlagt 28. sep. 1981 (86) International ansøgning nr.(21) Application No. 5 ^ 51/75 (51) lnt.CI.3 C 12 P 19/14 (22) Filing Day 3 · Dec. 1975 (24) Race day 5 · dec. 1975 (41) Aim. available 5 Jun. 1976 (44) Presented 28 Sep. 1981 (86) International application no.
(86) International indleveringsdag (85) Videreførelsesdag - (62) Stamansøgning nr. -(86) International filing day (85) Continuation day - (62) Master application no. -
(30) Prioritet 4. dec. 1974, 529329, US(30) Priority 4 Dec. 1974, 529329, US
(71) Ansøger R. J. REYNOLDS TOBACCO COMPANY, Winston-Salem, US.(71) Applicant R. J. REYNOLDS TOBACCO COMPANY, Winston-Salem, US.
(72) Opfinder Margaret E. Long, US: Chin K. Lee, US.(72) Inventor Margaret E. Long, US: Chin K. Lee, US.
(74) Fuldmægtig Ingeniørfirmaet Hofman-Bang & Bout ard.(74) Associate Engineer Hofman-Bang & Bout ard.
(54) Fremgangsmåde til hydrolyse af lactose under dannelse af glu»= cose og galactose.(54) Process for hydrolysis of lactose to form glu »= cose and galactose.
Den foreliggende opfindelse angår en fremgangsmåde til hydrolyse af lactose under dannelse af glucose og galactose, og fremgangsmåden ifølge opfindelsen er ejendommelig ved, at man bringer lac-tosen i kontakt med en lactase produceret ved dyrkning, af organismen Bacillus coagulans NRRL B-8100 i et lactoseholdigt næringsmedium.The present invention relates to a process for hydrolysis of lactose to form glucose and galactose, and the process of the invention is characterized by contacting the lactose with a lactase produced by cultivation of the organism Bacillus coagulans NRRL B-8100 in a lactose-containing nutrient medium.
q Der har i de senere år været betydelig interesse for at ud- j. vikle metoder til reduktion af lactoseindholdet i mælk og “ produkter afledt af mælk. Denne interesse er blevet forøget r) ved nylige påvisninger af, at en stor procentdel af den men- £ neskelige befolkning lider af lactasemangel, hvilket enten er en nedarvet egenskab eller et resultat af "en ældningsproces.q In recent years, there has been considerable interest in pursuit. develop methods for reducing the lactose content of milk and “products derived from milk. This interest has been heightened by recent evidence that a large percentage of the human population suffers from lactase deficiency, which is either an inherited property or a result of "an aging process.
t 2 143714 Sådanne lactasemangler fører til forstyrrelser i tarmkanalen, hvor fødens indhold af lactose er højt. Endvidere har man observeret en lignende lactoseintolerance hos visse husdyr.t 2 143714 Such lactase deficiency leads to intestinal tract disorders where the lactose content of the food is high. Furthermore, similar lactose intolerance has been observed in some domestic animals.
Hydrolysen af lactose i mælk og produkter afledt af mælk under dannelse af glucose og galactose er et attraktivt mål, ikke bare fordi det ville løse lactoseintoleranceproblemet, men også fordi det ville forøge sødheden af produkterne og reducere de såkaldte sandagtige texturer i visse mælkeafledte produkter, forårsaget af lactosekrystallisation. Fagfolk har længe erkendt ønskeligheden af at fremkalde denne hydrolyse ved anvendelse af lactase. Til trods for det forhold, at lactase forekommer relativt udbredt i naturen og produceres af mange mikroorganismer, har anvendelsen af lactase ved kommerciel produktion af mælk og produkter afledt af mælk været meget begrænset. En af årsagerne til den begrænsede kommercielle anvendelse af lactase er, at mange af de almindelige lactaser, såsom lactaser afledt af gær, udviser en optimal enzymaktivitet ved temperaturer, der også fører til bakterievækst. Som følge heraf har der været en stigende interesse i at finde lactase med en høj grad af termostabilitet. En sådan termo-stabil lactase ville tillade udførelse af lactosehydrolysen under betingelser, som er ikke-favorable for væksten af visse bakterier, der hyppigt er til stede i mælk eller produkter afledt af mælk. En sådan lactase afledt af Streptomyces coelicolor er beskrevet i USA-patentskrift nr. 3.816.259.The hydrolysis of lactose in milk and milk-derived products to form glucose and galactose is an attractive target not only because it would solve the lactose intolerance problem, but also because it would increase the sweetness of the products and reduce the so-called sandy textures in certain milk-derived products, caused of lactose crystallization. Those skilled in the art have long recognized the desirability of inducing this hydrolysis using lactase. Despite the fact that lactase is relatively widespread in nature and produced by many microorganisms, the use of lactase in the commercial production of milk and milk-derived products has been very limited. One of the reasons for the limited commercial use of lactase is that many of the common lactases, such as yeast derived lactases, exhibit optimal enzyme activity at temperatures also leading to bacterial growth. As a result, there has been a growing interest in finding lactase with a high degree of thermostability. Such thermostable lactase would allow lactose hydrolysis to be carried out under conditions which are unfavorable to the growth of certain bacteria frequently present in milk or milk derived products. Such a lactase derived from Streptomyces coelicolor is described in U.S. Patent No. 3,816,259.
Det er på dette tidspunkt ikke klart, hvorvidt lactase fra S. coelicolor kan anvendes uden risiko, fordi visse medlemmer af denne art har vist sig at producere antibiotika.It is not clear at this time whether S. coelicolor lactase can be used without risk because some members of this species have been shown to produce antibiotics.
Produktionen af lactase af medlemmer af Bacillus-slægten er tidligere beskrevet. Således har P.J. Anema, Biochem. Biophys.The production of lactase by members of the Bacillus genus has been described previously. Thus, P.J. Anema, Biochem. Biophys.
Acta, §2 (3), 495-502 (1964) beskrevet isolation af lactase fra B. subtilis. Lactase fra B. megaterium er beskrevet af S.R. Rohlfing og I.P. Crawford, J. Bacteriology 92 (4), 1258-9 (1966). Ingen af disse organismer kan imidlertid betragtes som varmetolerante, og den dannede lactase må i reglen anvendes ved temperaturer under 50° C for at bevare en nyttig 3 143714 enzymaktivitet i længere tid.Acta, §2 (3), 495-502 (1964) described the isolation of lactase from B. subtilis. B. megaterium lactase is described by S.R. Rohlfing and I.P. Crawford, J. Bacteriology 92 (4), 1258-9 (1966). However, none of these organisms can be considered heat-tolerant, and the lactase formed must generally be used at temperatures below 50 ° C to maintain useful enzyme activity for an extended period of time.
Det er formålet med den foreliggende opfindelse at angive en fremgangsmåde til hydrolyse af lactose under dannelse af glucose og galactose ved relativt høje temperaturer på op til 70^0, især mellem 45 og 65°C, og dette opnås ved, at man bringer lac-tosen i kontakt med en lactase, der er produceret ved dyrkning af en hidtil ukendt organisme af slægten Bacillus med særligt fordelagtige egenskaber. Således udviser den en optimal vækst ved en temperatur på mindst ca. 45^0. Organismen, der betegnes Bacillus coagulans NRRL B-8100 dyrkes i et næringsmedium indeholdende lactose, hvorefter den dannede lactase isoleres.It is the object of the present invention to provide a process for the hydrolysis of lactose to form glucose and galactose at relatively high temperatures of up to 70 ° C, especially between 45 and 65 ° C, and this is achieved by toxin in contact with a lactase produced by the cultivation of a novel organism of the genus Bacillus with particularly advantageous properties. Thus, it exhibits optimum growth at a temperature of at least approx. 45 ^ 0th The organism, designated Bacillus coagulans NRRL B-8100, is grown in a nutrient medium containing lactose and then the lactase formed is isolated.
Den anvendte organisme til dette formål er isoleret fra en jordprøve. Dyrkning af organismen i et passende næringsmedium indeholdende lactose fører til dannelsen af den ønskede lactase intracellulært. Der er foretaget en karakteristik af kulturen, og den er identificeret som faldende inden for arten Bacillus coagulans i overensstemmelse med klassifikationen efter Bergey's Manual of Determinative Bacteriology, 7th Edition. Denne organisme er deponeret i kultursamlingen i U.S.D.A. Northern Regional Research Laboratory under betegnelsen NRRL B-8100. De taxonomiske egenskaber af denne stamme er beskrevet i nedenstående tabel 1.The organism used for this purpose is isolated from a soil sample. Cultivation of the organism in a suitable nutrient medium containing lactose leads to the formation of the desired lactase intracellularly. A characteristic of the culture has been made and it has been identified as declining within the species Bacillus coagulans according to the classification according to Bergey's Manual of Determinative Bacteriology, 7th Edition. This organism is deposited in the cultural collection of the U.S.D.A. Northern Regional Research Laboratory under the designation NRRL B-8100. The taxonomic properties of this strain are described in Table 1 below.
TABEL 1 A. Morphologiske karakteristika: 1. Vegetative stave: Mindre end 0,9 um i diameter, læng den varierende i reglen op til 5,0 - 6,0 μιη. Enkelte filamenter. Ingen kæder. Gram positiv, ensartet farvning. Bevægelig.TABLE 1 A. Morphological characteristics: 1. Vegetative rods: Less than 0.9 µm in diameter, length varying in general up to 5.0 - 6.0 µιη. Some filaments. No chains. Gram positive, uniform staining. Movable.
2. Sporangier: I reglen ikke opsvulmede, men enkelte opsvulmede bronchier kan findes.2. Sporangia: As a rule, not swollen, but some swollen bronchi can be found.
3. Sporer: 0,9 x 1,2 - 1,5 pm, ellipsoidiske, subterminale Indtil terminale.3. Spores: 0.9 x 1.2 - 1.5 µm, ellipsoidal, subterminal Until terminal.
4 U37U4 U37U
B. Dyrkningsmæssige karakteristika: 1. Gelatine-agar Ingen hydrolyse, stregkultur: 2. Agarkolonier: Uigennemsigtige, små, runde.B. Cultural characteristics: 1. Gelatin agar No hydrolysis, line culture: 2. Agar colonies: Opaque, small, round.
Ikke skelnelige.Not distinguishable.
3. Agarskråkulturer: Spredt til moderat vækst. Flad, glat, gennemsigtig.3. Agar slant cultures: Scattered to moderate growth. Flat, smooth, transparent.
4. Glucose-agar Væksten kraftigere end på nærings- skråkultur: agar. Glat, hvid.4. Glucose agar Growth more powerful than nutritional culture: agar. Smooth, white.
5. Glucose-asparagin Ingen vækst i 24 timer, agarskråkultur: Moderat vækst efter 48 timer.5. Glucose asparagine No growth for 24 hours, agar culture: Moderate growth after 48 hours.
6. Sure proteose- God vækst, bedre end på nærings- pepton-agarskrå- agar.6. Acid Proteosis- Good growth, better than on nutrient peptone agar goblet.
kulturer: 7. Sojabønneagar- Moderat vækst, lidt stærkere end skråkulturer: på næringsagar.cultures: 7. Soybean agar- Moderate growth, slightly stronger than oblique cultures: on nutrient agar.
8. Skråkultur på Spredt vækst efter 24 timer, agar til opbe- lige så god som næringsagar ved varing: 48 timer.8. Slant culture on Scattered growth after 24 hours, agar for living as good as nutritional agar for lasting: 48 hours.
9. Kødsuppe: Ringe vækst efter 24 timer.9. Meat Soup: Poor growth after 24 hours.
10. Natriumchlorid- Ingen vækst i 7 % natriumchlorid. kødsuppe: 11. Mælkeagar streg- Ingen hydrolyse, kultur: 12. Kartoffel: Spredt, tør, rynket.10. Sodium Chloride- No growth in 7% sodium chloride. meat soup: 11. Milk agar line- No hydrolysis, culture: 12. Potato: Scattered, dry, wrinkled.
C. Fysiologiske karakteristika: 1. Under anvendelse af pepton som nitrogehkilde producerede organismen syre, men ingen gasser ud fra glucose, lactose, arabinose, xylose, mannitol og maltose.C. Physiological characteristics: 1. Using peptone as a nitrogen source, the organism produced acid but no gases from glucose, lactose, arabinose, xylose, mannitol and maltose.
Neutral reaktion på saccharose og glycerol.Neutral reaction to sucrose and glycerol.
2. pH i glucosenæringsvæske er 5,0 eller mindre på 7 dage.2. The pH of glucose nutrient fluid is 5.0 or less in 7 days.
3. Ingen citratudnyttelse.3. No citrate utilization.
4. Tomatgærmælk løb sammen efter 24 timer ved 45° C, 5. Ingen produktion af nitriter fra nitrater.4. Tomato yeast milk ran out after 24 hours at 45 ° C, 5. No production of nitrates from nitrates.
6. Negativ Voges-Proskauer-test. pH i Voges-Proskauer-væsken var 4,2.6. Negative Voges-Proskauer test. The pH of the Voges-Proskauer liquid was 4.2.
7· Positiv stivelseshydrolyse.7 · Positive starch hydrolysis.
5 143714 8, Positiv katalasereaktion.Positive catalase reaction.
9. Ingen vaskst på nitratholdigt medium under anaerobe betingelser. Vækst på glucosenæringsvæske under anaerobe betingelser fører til pH under 5,2 i løbet af 7 dage.9. No washing on nitrate-containing medium under anaerobic conditions. Growth on glucose nutrient fluid under anaerobic conditions leads to pH below 5.2 over 7 days.
10. Aerob, fakultativt anaerobt, 11. Minimumstemperatur for væksten er 25° C, Maksimumstemperaturen for vækst er 60° G. Optimalvækst ved 45 - 50° C.10. Aerobic, optional anaerobic, 11. Minimum temperature for growth is 25 ° C, Maximum temperature for growth is 60 ° G. Optimal growth at 45 - 50 ° C.
Som angivet under de fysiologiske karakteristika i tabel 1 udviser den beskrevne Baeillus-organisme optimal vækst ved temperaturer på cirka 45 - 50° C og kan derfor opfattes som en varmetolerant organisme i sammenligning med andre Bacillus*· o arter, der udviser optimal vækst ved cirka 37 C. En varmetolerant Baeillus-organisme defineres her som en organisme, der udviser optimal vækst ved temperaturer på cirka 45° C og derover.As indicated under the physiological characteristics of Table 1, the described Baeillus organism exhibits optimum growth at temperatures of about 45 - 50 ° C and can therefore be perceived as a heat tolerant organism in comparison to other Bacillus * o species exhibiting optimum growth at ca. 37 C. A heat-tolerant Baeillus organism is defined herein as an organism that exhibits optimum growth at temperatures of about 45 ° C and above.
Opfindelsen illustreres nærmere ved nedenstående eksempel.The invention is further illustrated by the following example.
EKSEMPELEXAMPLE
pH-optimum for den af organismen producerede lactase bestemtes ved at analysere hele celler i nærvær af o-nitrophenyl-β-galactosid (ONPG) som substrat. Man gik frem i det væsentlige som beskrevet af J. Lederberg, J. Bacteriology 60, 381 (1950). Cellerne blev først behandlet med toluen, der anvendtes en phosphatpuffer, og analysetemperaturen var 37° C, Lactaseaktiviteten observeredes i intervallet pH cirka 4,5 - 8,0, med optimal aktivitet ved cirka pH 6,0.The pH optimum for the lactase produced by the organism was determined by analyzing whole cells in the presence of o-nitrophenyl-β-galactoside (ONPG) as a substrate. It proceeded essentially as described by J. Lederberg, J. Bacteriology 60, 381 (1950). The cells were first treated with toluene using a phosphate buffer and the assay temperature was 37 ° C.
Stabiliteten af lactasen produceret af B, coagulans vurderedes ved at anvende ONPG som substrat i en modificeret Leder-berg-fremgangsmåde. Til denne undersøgelse suspenderedes udvaskede celler i 0,05 M phospha tpuf fer ved pH 7,0 i nærvær 6 143714 af ONPG-substratet. Suspensionen holdtes ved 60° C i fire dage, idet prøver periodisk udtoges til bestemmelse af den tilbageværende lactaseaktivitet. Temperaturen ved denne stabilitetsprøve valgtes som tilnærmelsesvis de anvendte temperaturniveauer ved lavtemperatur-pasteurisering. Resultaterne af prøverne er vist i tabel 2.The stability of the lactase produced by B, coagulans was assessed by using ONPG as a substrate in a modified Leder-Berg method. For this study, washed out cells were suspended in 0.05 M phosphate buffer at pH 7.0 in the presence of the ONPG substrate. The suspension was kept at 60 ° C for four days, taking samples periodically to determine residual lactase activity. The temperature of this stability test was chosen as approximately the temperature levels used in low temperature pasteurization. The results of the tests are shown in Table 2.
TABEL 2TABLE 2
Tid (timer) Lactaseaktivitet som pot.Time (hours) Lactase activity as pot.
af oprindelig aktivitet 0 100 21 92 45 51 71 36 99 20of initial activity 0 100 21 92 45 51 71 36 99 20
Lactasen produceret af Bacillus coagulans udviser nyttig enzymaktivitet op til 70° C. Optimal aktivitet synes at forekomme ved temperaturer på 60 - 65° C. Den specielle temperatur, der vælges til gennemførelse af lactosehydrolyse ved anvendelse af dette enzym, vil afhænge noget af det anvendte substratmedium. Generelt foretrækkes imidlertid temperaturer på 45 - 65° C.The lactase produced by Bacillus coagulans exhibits useful enzyme activity up to 70 ° C. Optimal activity appears to occur at temperatures of 60-65 ° C. The particular temperature selected for carrying out lactose hydrolysis using this enzyme will depend on some of the enzyme used. substratmedium. Generally, however, temperatures of 45 - 65 ° C are preferred.
Et typisk medium til dyrkning af Bacillus coagulans under produktion af lactase har følgende sammensætning:A typical medium for growing Bacillus coagulans during lactase production has the following composition:
Proteose-pepton.......................... 1,0 % Gærekstrakt................i............. 1,0 %Proteose-peptone .......................... 1.0% Yeast Extract ................ i ............. 1.0%
Kaliumdihydrogenphosphat ................. 0,8 %Potassium dihydrogen phosphate ................. 0.8%
Lactose (steriliseret separat) ........... 2,0 % pH....................................... 6,0Lactose (sterilized separately) ........... 2.0% pH ............................. .......... 6.0
Kulturer inkuberes på en roterende ryster i 48 timer ved 45° C. Efter afslutning af inkubationsperioden tilsættes toluenCultures are incubated on a rotary shaker for 48 hours at 45 ° C. After completion of the incubation period, toluene is added.
7 14371A7 14371A
til væsken (0,5 % på volumeribasis), og blandingen omrøres i 30 minutter. Cellerne udvindes derpå ved flokkulering, som beskrevet i USA-patentskrift nr. 3*821.086, og det opnåede flokkulerede celleaggregat tørres ved 55° C. Lactase-aktiviteten af de tørrede aggregerede partikler er 38,5 enheder pr. gram, hvor en enhed defineres som den mængde enzym, der er nødvendig til dannelse af et mikromol dextrose pr. minut under prøvebetingelserne. Den anvendte prøvemetode er beskrevet af Weetall et al., Biotechnology and Bioengineering 16, 295 (1974).to the liquid (0.5% by volume) and the mixture is stirred for 30 minutes. The cells are then recovered by flocculation, as described in U.S. Patent No. 3 * 821,086, and the resulting flocculated cell aggregate is dried at 55 ° C. The lactase activity of the dried aggregate particles is 38.5 units per minute. grams, where one unit is defined as the amount of enzyme needed to generate one micromole of dextrose per gram. minute under the test conditions. The test method used is described by Weetall et al., Biotechnology and Bioengineering 16, 295 (1974).
Effektiviteten af den af Bacillus coagulans producerede lactase demonstreredes ved hydrolyse af lactose i en sød lagret valle. Organismen dyrkedes, og cellerne udvandtes som beskrevet ovenfor. De tørrede aggregerede partikler frasigtedes, og 5 g af 16-20 mesh portionen (0,017-0,024/um) hydratiseredes i en 50% lactoseopløsning pufret til pH 7,0 med en 0,05 phosphatpuf-fer. De hydratiserede partikler anbragtes derpå i en lille glaskolonne, der holdtes ved en temperatur på 60° C. Gennem denne pakkede kolonne ledtes kontinuerligt en vandig opløsning indeholdende 70 gram af et kommercielt tørret sødt vallepulver pr. liter, idet opløsningen pufredes med 0,05 M phosphat til pH 7,0. Opløsningen indeholdt cirka 5 vægtprocent lactose, beregnet på lactoseindholdet i den søde valle, og der tilsattes 100 mg/liter methyl-p-hydroxybenzoat som konserveringsmiddel. Strømningshastigheden gennem kolonnen holdtes på 375 ml/dag, og graden af lactosehydrolyse bestemtes dagligt ved rutineanalyse. Begyndelsesgraden for lactosehydrolysen viste sig at være 90 pct. Efter 3 ugers kontinuert drift var hydrolysegraden faldet til 80 pct.The efficacy of the lactase produced by Bacillus coagulans was demonstrated by the hydrolysis of lactose in a sweet stored whey. The organism was cultured and the cells were watered as described above. The dried aggregate particles were sieved and 5 g of the 16-20 mesh portion (0.017-0.024 µm) hydrated in a 50% lactose solution buffered to pH 7.0 with a 0.05 phosphate buffer. The hydrated particles were then placed in a small glass column maintained at a temperature of 60 ° C. Through this packed column, an aqueous solution containing 70 grams of a commercially dried sweet whey powder was continuously passed. The solution is buffered with 0.05 M phosphate to pH 7.0. The solution contained about 5% by weight of lactose, calculated on the lactose content of the sweet whey, and 100 mg / liter of methyl p-hydroxybenzoate was added as a preservative. The flow rate through the column was maintained at 375 ml / day and the degree of lactose hydrolysis was determined daily by routine analysis. The initial rate of lactose hydrolysis was found to be 90 per cent. After 3 weeks of continuous operation, the degree of hydrolysis had dropped to 80 per cent.
Det er klart, at den fremstillede lactase kan anvendes enten til batchvis eller kontinuert behandling ved lactoseholdige substrater. Endvidere kan lactasen anvendes ved direkte anvendelse af cellerne, eller den kan anvendes i form af det cellefri enzym ved i sig selv kendte metoder.It will be appreciated that the lactase produced can be used either for batch or continuous treatment with lactose-containing substrates. Furthermore, the lactase can be used by direct use of the cells or it can be used in the form of the cell-free enzyme by methods known per se.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK197378A DK143711C (en) | 1974-12-04 | 1978-05-05 | METHOD FOR MANUFACTURING LACTASE WITH IMPROVED THERMOSTABILITY |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US52932974A | 1974-12-04 | 1974-12-04 | |
US52932974 | 1974-12-04 |
Publications (3)
Publication Number | Publication Date |
---|---|
DK545175A DK545175A (en) | 1976-06-05 |
DK143714B true DK143714B (en) | 1981-09-28 |
DK143714C DK143714C (en) | 1982-03-22 |
Family
ID=24109461
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK545175A DK143714C (en) | 1974-12-04 | 1975-12-03 | METHOD FOR HYDROLYSE OF LACTOSE UNDER GLUCOSE AND GALACTOSE CREATION |
Country Status (8)
Country | Link |
---|---|
BE (1) | BE836246A (en) |
CA (1) | CA1055416A (en) |
CH (1) | CH611647A5 (en) |
DE (1) | DE2554407A1 (en) |
DK (1) | DK143714C (en) |
FR (1) | FR2293490A1 (en) |
GB (1) | GB1493542A (en) |
NL (1) | NL7514110A (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS53148591A (en) | 1977-05-31 | 1978-12-25 | Daiwa Kasei Kk | Production of novel lactase |
NZ190603A (en) * | 1978-06-07 | 1982-03-23 | Nat Res Dev | Heat-stable -galactosidase derived from bacillus stearothermophilus hydrolysis of lactose |
DK146325C (en) * | 1979-01-10 | 1984-02-20 | Novo Industri As | BETA-GALACTOSIDASE, METHOD OF PREPARING IT AND USING THEREOF |
US6428786B1 (en) | 1993-09-28 | 2002-08-06 | Mcneil-Ppc, Inc. | Composition and method for lactose hydrolysis |
US6057139A (en) | 1995-06-29 | 2000-05-02 | Mcneil-Ppc, Inc. | Preblend of microcrystalline cellulose and lactase for making tablets |
-
1975
- 1975-11-18 GB GB4752075A patent/GB1493542A/en not_active Expired
- 1975-12-03 CH CH1574175A patent/CH611647A5/en not_active IP Right Cessation
- 1975-12-03 DE DE19752554407 patent/DE2554407A1/en not_active Ceased
- 1975-12-03 FR FR7536980A patent/FR2293490A1/en active Granted
- 1975-12-03 DK DK545175A patent/DK143714C/en not_active IP Right Cessation
- 1975-12-03 CA CA240,972A patent/CA1055416A/en not_active Expired
- 1975-12-03 BE BE1007052A patent/BE836246A/en unknown
- 1975-12-03 NL NL7514110A patent/NL7514110A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
FR2293490A1 (en) | 1976-07-02 |
DK143714C (en) | 1982-03-22 |
BE836246A (en) | 1976-06-03 |
CH611647A5 (en) | 1979-06-15 |
CA1055416A (en) | 1979-05-29 |
FR2293490B1 (en) | 1979-08-10 |
NL7514110A (en) | 1976-06-09 |
GB1493542A (en) | 1977-11-30 |
DK545175A (en) | 1976-06-05 |
DE2554407A1 (en) | 1976-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4323651A (en) | Thermostable lactase derived from bacillus | |
Nimisha et al. | Amylase activity of starch degrading bacteria isolated from soil | |
US3826714A (en) | Thermophilic glucose isomerase enzyme preparation | |
EP0006035B1 (en) | Bacterial beta-galactosidase, immobilized forms thereof, process for their preparation and use in the hydrolysis of lactose, and novel bacteria | |
US3979261A (en) | Production of glucose isomerase by bacillus coagulans | |
Ramapriya et al. | Partial purification and characterization of exoinulinase produced from Bacillus sp. | |
Pompeyo et al. | Comparison of amylolytic properties of Lactobacillus amylovorus and of Lactobacillus amylophilus | |
RU2288263C2 (en) | Strain bacillus coagulants sim-7 dsm 14043 for preparing l-(+)-lactate and method for preparing l-(+)-lactate | |
US4179335A (en) | Thermostable lactase derived from Bacillus coagulans | |
DK143714B (en) | METHOD FOR HYDROLYSE OF LACTOSE UNDER GLUCOSE AND GALACTOSE CREATION | |
JP3763005B2 (en) | Bacteria strains with phenotypes closely related to Lactobacillus, culture methods and uses | |
Yoshida et al. | Production and application of maltose phosphorylase and trehalose phosphorylase by a strain of Plesiomonas | |
SU764617A3 (en) | Method of preparing glucoisomerase | |
JPH06506107A (en) | Xylanase, xylanase-producing Bacillus strains and their use | |
RShalinimol | Identification and Evaluation of Bacillus Species Bacteria from Sago Industrial Waste | |
DK143711B (en) | METHOD FOR MANUFACTURING LACTASE WITH IMPROVED THERMOSTABILITY | |
NO131605B (en) | ||
Malik et al. | Effect of some nutritional and environmental factors on extracellular protease production by Pseudomonas sp. B-25 | |
Veetil et al. | Characterization of Alcaligenes faecalis GPA-1 producing thermostable extracellular α-amylase | |
Hartley et al. | β-Galactosidase of Propionibacterium shermanii | |
JPH0358713B2 (en) | ||
US3843445A (en) | Asparaginase production | |
Sharma et al. | Amylase producing efficiency of Bacillus species isolated from Jammu soil | |
Take Ajaykumar et al. | Production and characterization of α-amylase isolated from Aspergillus niger by Solid State Fermentation | |
Hashem et al. | Production and optimization of extracellular α-amylase from halophilic bacteria Cytobacillus oceanisediminis isolated from Wadi-El-Natrun, Egypt |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PBP | Patent lapsed |